Eli Lilly and Co
NYSE:LLY

Watchlist Manager
Eli Lilly and Co Logo
Eli Lilly and Co
NYSE:LLY
Watchlist
Price: 839.96 USD 14.3% Market Closed
Market Cap: 796.3B USD

Intrinsic Value

The intrinsic value of one LLY stock under the Base Case scenario is 374.63 USD. Compared to the current market price of 839.96 USD, Eli Lilly and Co is Overvalued by 55%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

LLY Intrinsic Value
374.63 USD
Overvaluation 55%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Eli Lilly and Co

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
LLY
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for LLY cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Eli Lilly and Co
NYSE:LLY
US
Pharmaceuticals
Market Cap
795.9B USD
IPO
Jul 9, 1970
US
Pharmaceuticals
Market Cap
795.9B USD
IPO
Jul 9, 1970
Price
$false
EPS
$false
Company Overview
Loading...
Business Segments
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
Bear Theses

Despite the significant buzz around tirzepatide and other diabetes products, their high development and marketing costs could erode profitability if insurance reimbursement or pricing pressures intensify, particularly in today’s cost-conscious healthcare environment.

Bull Theses

Tirzepatide’s rapid approvals and robust clinical outcomes in diabetes and obesity treatments position Eli Lilly to capture valuable market share in a high-growth therapeutic area, protecting long-term revenue streams.

Show More Less
How do you feel about LLY?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Eli Lilly and Co
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Eli Lilly and Co

Current Assets 32.7B
Cash & Short-Term Investments 3.4B
Receivables 13.3B
Other Current Assets 16B
Non-Current Assets 46B
Long-Term Investments 3.2B
PP&E 17.1B
Intangibles 11.9B
Other Non-Current Assets 13.7B
Efficiency

Free Cash Flow Analysis
Eli Lilly and Co

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Eli Lilly and Co

Revenue
45B USD
Cost of Revenue
-8.4B USD
Gross Profit
36.6B USD
Operating Expenses
-19.6B USD
Operating Income
17B USD
Other Expenses
-6.5B USD
Net Income
10.6B USD
Fundamental Scores

LLY Profitability Score
Profitability Due Diligence

Eli Lilly and Co's profitability score is 75/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROE
Positive Gross Profit
Exceptional ROE
Positive Operating Income
75/100
Profitability
Score

Eli Lilly and Co's profitability score is 75/100. The higher the profitability score, the more profitable the company is.

LLY Solvency Score
Solvency Due Diligence

Eli Lilly and Co's solvency score is 65/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Long-Term Solvency
Short-Term Solvency
65/100
Solvency
Score

Eli Lilly and Co's solvency score is 65/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

LLY Price Targets Summary
Eli Lilly and Co

Wall Street analysts forecast LLY stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for LLY is 1 043.17 USD with a low forecast of 808 USD and a high forecast of 1 249.5 USD.

Lowest
Price Target
808 USD
4% Downside
Average
Price Target
1 043.17 USD
24% Upside
Highest
Price Target
1 249.5 USD
49% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for LLY is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

LLY Insider Trading
Buy and sell transactions by insiders

LLY News

Other Videos
What is the Intrinsic Value of one LLY stock?

The intrinsic value of one LLY stock under the Base Case scenario is 374.63 USD.

Is LLY stock undervalued or overvalued?

Compared to the current market price of 839.96 USD, Eli Lilly and Co is Overvalued by 55%.

Back to Top